Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

As a result, it will be available only on private prescription at a cost of €215 or more a month. That equates to an annual ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...

WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...

This study provides valuable insight into the increasing use of obesity drugs. The rising prescription numbers suggest that ...

The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...

As a weight loss drug, semaglutide is intended to be used ... Zepbound (tirzepatide) and Saxenda (liraglutide) are two other options FDA-approved for weight management. It’s also possible ...

STRUGGLING to keep up with her two young children and dreading her own reflection in the mirror, Emma Lasenby knew something ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.